China's WuXi XDC jumps most in 9 weeks on robust results forecast

WuXi XDC Cayman

01/02/2024 05:02

** Shares of Chinese antibody drug conjugates research,
development and manufacturing services provider WuXi XDC Cayman
Inc  2268.HK  jump 11.1% to HK$22.10, on track for the biggest
one-day pct rise since Dec 1 if gains hold
    ** WuXi XDC says it expects its 2023 revenue to jump over
100% YoY with net profit up over 80% YoY thanks to development
of antibody-drug conjugate industry and its competitive
strengths in winning projects
    ** Shares of its parent WuXi Biologics (Cayman)  2269.HK 
surges 5.6%
    ** Hong Kong's healthcare index  .HSCIH  surges 3.4%, Hang
Seng Composite Index  .HSCI  and Hang Seng Index  .HSI  both
rise 1.4%
    ** WuXi XDC shares down 31.6% YTD, WuXi Biologics down 26.9%
YTD 

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))